Literature DB >> 14522411

Pathophysiology of the heart in Chagas' disease: current status and new developments.

Maria de Lourdes Higuchi1, Luiz Alberto Benvenuti, Marcia Martins Reis, Martin Metzger.   

Abstract

In the present review we have summarized remarkable historical data on Chagas' disease studies putting special emphasis on histopathological findings and pathogenetic theories as well as recent discoveries based on the use of advanced modern technologies in pathology and immunology. A unified theory that links almost all of these findings is proposed. Chronic cardiac Chagas' disease represents the result of a close interaction between the host and the parasite, causing different clinical pictures: patients with an efficient immune response may adequately circumvent the parasitic infection and the individual will develop the indeterminate form. Deficient immune response of the host and/or a high initial parasitemia favor an immune imbalance that might lead to development of a permanent inadequate immunological response against the parasite. The inflammatory response, which is probably recurrent, undergoing periods of more accentuated exacerbation, is most likely responsible for progressive neuronal damage, microcirculatory alterations, heart matrix deformations and consequent organ failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522411     DOI: 10.1016/s0008-6363(03)00361-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  89 in total

Review 1.  A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

Authors:  Maria Ângela B Trindade; Noemia B Carvalho; Elaini C Belfort; Carla Pagliari; Erika Gakiya; Neusa Y Sakai-Valente; Gil Benard; Maria A Shikanai-Yasuda
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.

Authors:  Nisha Garg; Arpad Gerstner; Vandanajay Bhatia; James DeFord; John Papaconstantinou
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi.

Authors:  Daniel Adesse; Dumitru A Iacobas; Sanda Iacobas; Luciana R Garzoni; Maria de Nazareth Meirelles; Herbert B Tanowitz; David C Spray
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease.

Authors:  Monisha Dhiman; Nisha Jain Garg
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

5.  Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.

Authors:  Kathryn Jones; Leroy Versteeg; Ashish Damania; Brian Keegan; April Kendricks; Jeroen Pollet; Julio Vladimir Cruz-Chan; Fabian Gusovsky; Peter J Hotez; Maria Elena Bottazzi
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

6.  Brain natriuretic peptide predicts survival in Chagas' disease more effectively than atrial natriuretic peptide.

Authors:  S Heringer-Walther; M C V Moreira; N Wessel; J L Saliba; J Silvia-Barra; J L B Pena; S Becker; W E Siems; H P Schultheiss; T Walther
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

7.  Low-Level Parasite Persistence Drives Vasculitis and Myositis in Skeletal Muscle of Mice Chronically Infected with Trypanosoma cruzi.

Authors:  Joseph D Weaver; Victoria J Hoffman; Ester Roffe; Philip M Murphy
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

8.  High fat diet aggravates cardiomyopathy in murine chronic Chagas disease.

Authors:  Kezia Lizardo; Janeesh Plakkal Ayyappan; Min-Hui Cui; Rashmi Balasubramanya; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2018-07-31       Impact factor: 2.700

9.  Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes.

Authors:  Fabiana S Machado; Janeusa T Souto; Marcos A Rossi; Lisia Esper; Herbert B Tanowitz; Julio Aliberti; João S Silva
Journal:  Microbes Infect       Date:  2008-10-08       Impact factor: 2.700

10.  Acute Trypanosoma cruzi experimental infection induced renal ischemic/reperfusion lesion in mice.

Authors:  Gabriel Melo de Oliveira; Tshaca Mahatma da Silva; Wanderson Silva Batista; Marcello Franco; Nestor Schor
Journal:  Parasitol Res       Date:  2009-09-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.